Quantification of immunolabelled cells in situ confirmed increased CD8+ CTLs and CD4+ Th cells, with FoxP3+ Treg cell numbers remaining unchanged in the Cx3cr1‐Rheb1Δ/Δ tumours (Fig 4D). The gene discussed is FOXP3; the disease is neoplasm.